References

Sarcopenia: Origins and Clinical Relevance

10.1093/jn/127.5.990s · 1997 · External reference

Sarcopenia: Revised European Consensus on Definition and Diagnosis

10.1093/ageing/afy169 · 2019 · External reference

Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD‐10‐CM) Code

10.1016/j.jamda.2016.06.001 · 2016 · External reference

Prevalence of and Interventions for Sarcopenia in Ageing Adults: A Systematic Review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)

2014 · External reference

Sarcopenia: European Consensus on Definition and Diagnosis: Report of the European Working Group on Sarcopenia in Older People

10.1093/ageing/afq034 · 2010 · External reference

International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management

10.1007/s12603-018-1139-9 · 2018 · External reference

Does Nutrition Play a Role in the Prevention and Management of Sarcopenia?

10.1016/j.clnu.2017.08.016 · 2018 · External reference

A Phase IIA Randomized, Placebo‐Controlled Clinical Trial to Study the Efficacy and Safety of the Selective Androgen Receptor Modulator (SARM), MK‐0773 in Female Participants With Sarcopenia

10.1007/s12603-013-0335-x · 2013 · External reference

The Selective Androgen Receptor Modulator GTx‐024 (Enobosarm) Improves Lean Body Mass and Physical Function in Healthy Elderly Men and Postmenopausal Women: Results of a Double‐Blind, Placebo‐Controlled Phase II Trial

10.1007/s13539-011-0034-6 · 2011 · External reference

Myostatin Antibody (LY2495655) in Older Weak Fallers: A Proof‐of‐Concept, Randomised, Phase 2 Trial

10.1016/s2213-8587(15)00298-3 · 2015 · External reference

Treatment of Sarcopenia With Bimagrumab: Results From a Phase II, Randomized, Controlled, Proof‐of‐Concept Study

10.1111/jgs.14927 · 2017 · External reference

Urolithins: A Comprehensive Update on Their Metabolism, Bioactivity, and Associated Gut Microbiota

10.1002/mnfr.202101019 · 2022 · External reference

Urolithins: A Prospective Alternative Against Brain Aging

10.3390/nu15183884 · 2023 · External reference

Urolithins, the Rescue of ‘Old’ Metabolites to Understand a ‘New’ Concept: Metabotypes as a Nexus Among Phenolic Metabolism, Microbiota Dysbiosis, and Host Health Status

10.1002/mnfr.201500901 · 2017 · External reference

Where to Look Into the Puzzle of Polyphenols and Health? The Postbiotics and Gut Microbiota Associated With Human Metabotypes

10.1002/mnfr.201900952 · 2020 · External reference

The Mitophagy Activator Urolithin A Is Safe and Induces a Molecular Signature of Improved Mitochondrial and Cellular Health in Humans

10.1038/s42255-019-0073-4 · 2019 · External reference

Urolithin A Improves Muscle Strength, Exercise Performance, and Biomarkers of Mitochondrial Health in a Randomized Trial in Middle‐Aged Adults

10.1016/j.xcrm.2022.100633 · 2022 · External reference

Urolithin B, a Newly Identified Regulator of Skeletal Muscle Mass

10.1002/jcsm.12190 · 2017 · External reference

Using Polyphenol Derivatives to Prevent Muscle Wasting

2018 · External reference

Urolithin A Improves Muscle Function by Inducing Mitophagy in Muscular Dystrophy

10.1126/scitranslmed.abb0319 · 2021 · External reference

Direct Supplementation With Urolithin A Overcomes Limitations of Dietary Exposure and Gut Microbiome Variability in Healthy Adults to Achieve Consistent Levels Across the Population

10.1038/s41430-021-00950-1 · 2022 · External reference

A Simple, Rapid, and Sensitive DNA Assay Procedure

10.1016/0003-2697(80)90165-7 · 1980 · External reference

Current and Investigational Medications for the Treatment of Sarcopenia

10.1016/j.metabol.2023.155597 · 2023 · External reference

Pharmacological Effects of Urolithin A and Its Role in Muscle Health and Performance: Current Knowledge and Prospects

10.3390/nu15204441 · 2023 · External reference

Urolithin B, a Gut Microbiota Metabolite, Reduced Susceptibility to Myocardial Arrhythmic Predisposition After Hypoxia

10.1155/2022/6517266 · 2022 · External reference

Ellagic Acid‐Derived Urolithins as Modulators of Oxidative Stress

10.1155/2020/5194508 · 2020 · External reference

Interleukin‐17B Is a New Biomarker of Human Muscle Regeneration in Dystrophinopathies

10.1093/brain/awaf058 · 2025 · External reference

Inflammation and Sarcopenia: A Focus on Circulating Inflammatory Cytokines

10.1016/j.exger.2021.111544 · 2021 · External reference

The Diverse Functionality of NQO1 and Its Roles in Redox Control

10.1016/j.redox.2021.101950 · 2021 · External reference

The Inositol Phosphate System—A Coordinator of Metabolic Adaptability

10.3390/ijms23126747 · 2022 · External reference

Mitophagy Activation by Urolithin A to Target Muscle Aging

10.1007/s00223-023-01145-5 · 2024 · External reference

The Role of Protein Glycosylation in Muscle Diseases

10.1007/s11033-022-07334-z · 2022 · External reference

The Role of Inflammation in Age‐Related Sarcopenia

10.3389/fphys.2017.01045 · 2017 · External reference

Cholesterol and Skeletal Muscle Health

10.1159/000235713 · 2009 · External reference

Bidirectional Roles of Skeletal Muscle Fibro‐Adipogenic Progenitors in Homeostasis and Disease

10.1016/j.arr.2022.101682 · 2022 · External reference

Myosteatosis: Epidemiological Insights, Functional Decline, and Diagnostic Advances

10.1007/s13679-025-00676-2 · 2025 · External reference

The Chemokine Receptor CXCR4 Regulates Satellite Cell Activation, Early Expansion, and Self‐Renewal, in Response to Skeletal Muscle Injury

10.3389/fcell.2022.949532 · 2022 · External reference

The Effects of Death and Post‐Mortem Cold Ischemia on Human Tissue Transcriptomes

10.1038/s41467-017-02772-x · 2018 · External reference

Skeletal Muscle Stem Cells Adopt a Dormant Cell State Post Mortem and Retain Regenerative Capacity

10.1038/ncomms1890 · 2012 · External reference

New Perspectives for Postmortem Human Satellite Cells of Different Embryological Origin

10.3389/fphys.2022.886149 · 2022 · External reference